{"id":"https://openalex.org/W4397048499","doi":"https://doi.org/10.1681/asn.20233411s1281a","title":"Obinutuzumab in Combination with Avacopan in Rituximab-Resistant ANCA-Associated Vasculitis (AAV)","display_name":"Obinutuzumab in Combination with Avacopan in Rituximab-Resistant ANCA-Associated Vasculitis (AAV)","publication_year":2023,"publication_date":"2023-11-01","ids":{"openalex":"https://openalex.org/W4397048499","doi":"https://doi.org/10.1681/asn.20233411s1281a"},"language":"en","primary_location":{"id":"doi:10.1681/asn.20233411s1281a","doi":"https://doi.org/10.1681/asn.20233411s1281a","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.20233411s1281a","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027110549","display_name":"Yeshwanter Radhakrishnan","orcid":"https://orcid.org/0000-0002-1437-8894","observed_orcids":["https://orcid.org/0000-0002-1437-8894"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yeshwanter Radhakrishnan","raw_affiliation_strings":["Mayo Clinic Minnesota, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Minnesota, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012967877","display_name":"Ulrich Specks","orcid":"https://orcid.org/0000-0002-6559-1206","observed_orcids":["https://orcid.org/0000-0002-6559-1206"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ulrich Specks","raw_affiliation_strings":["Mayo Clinic Minnesota, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Minnesota, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073207965","display_name":"Fernando Custodio Fervenza","orcid":"https://orcid.org/0000-0002-9952-209X","observed_orcids":["https://orcid.org/0000-0002-9952-209X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fernando C. Fervenza","raw_affiliation_strings":["Mayo Clinic Minnesota, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Minnesota, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022727703","display_name":"Ladan Zand","orcid":"https://orcid.org/0000-0001-5812-9809","observed_orcids":["https://orcid.org/0000-0001-5812-9809"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ladan Zand","raw_affiliation_strings":["Mayo Clinic Minnesota, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Minnesota, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1330342723"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"34","issue":"11S","first_page":"281","last_page":"281"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10697","display_name":"Vasculitis and related conditions","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10697","display_name":"Vasculitis and related conditions","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/obinutuzumab","display_name":"obinutuzumab","score":0.9210000038146973},{"id":"https://openalex.org/keywords/avacopan","display_name":"avacopan","score":0.9980000257492065},{"id":"https://openalex.org/keywords/anca-associated-vasculitis","display_name":"ANCA-associated vasculitis","score":0.9789999723434448},{"id":"https://openalex.org/keywords/rituximab-resistance","display_name":"rituximab resistance","score":0.8769999742507935},{"id":"https://openalex.org/keywords/microscopic-polyangiitis","display_name":"microscopic polyangiitis","score":0.8679999709129333},{"id":"https://openalex.org/keywords/pauci-immune-necrotizing-glomerulonephritis","display_name":"pauci-immune necrotizing glomerulonephritis","score":0.875},{"id":"https://openalex.org/keywords/anti-cd20-therapy","display_name":"anti-CD20 therapy","score":0.8650000095367432},{"id":"https://openalex.org/keywords/c5a-receptor-antagonist","display_name":"C5a receptor antagonist","score":0.871999979019165},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6460000276565552},{"id":"https://openalex.org/keywords/mpo-anca","display_name":"MPO-ANCA","score":0.8500000238418579},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.41200000047683716},{"id":"https://openalex.org/keywords/hematuria","display_name":"hematuria","score":0.5860000252723694},{"id":"https://openalex.org/keywords/renal-function","display_name":"renal function","score":0.31200000643730164},{"id":"https://openalex.org/keywords/b-cell-depletion","display_name":"B-cell depletion","score":0.4659999907016754}],"concepts":[{"id":"https://openalex.org/C2777607594","wikidata":"https://www.wikidata.org/wiki/Q389496","display_name":"Obinutuzumab","level":4,"score":0.8319525718688965},{"id":"https://openalex.org/C2910998276","wikidata":"https://www.wikidata.org/wiki/Q7148839","display_name":"ANCA-Associated Vasculitis","level":4,"score":0.7883999347686768},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.7869023084640503},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7103108763694763},{"id":"https://openalex.org/C2776015282","wikidata":"https://www.wikidata.org/wiki/Q644318","display_name":"Vasculitis","level":3,"score":0.5330345034599304},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4895258843898773},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.36789435148239136},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29086875915527344},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.18536266684532166},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.12099212408065796}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1681/asn.20233411s1281a","doi":"https://doi.org/10.1681/asn.20233411s1281a","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.20233411s1281a","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4415423007","https://openalex.org/W4413803489","https://openalex.org/W4200218139","https://openalex.org/W4415893453","https://openalex.org/W4400726381","https://openalex.org/W4399483925","https://openalex.org/W4414291069","https://openalex.org/W2411351115","https://openalex.org/W7160998431","https://openalex.org/W2947437304"],"abstract_inverted_index":{"Introduction:":[0],"Rituximab":[1],"(RTX)":[2],"is":[3,200,210,348],"now":[4],"considered":[5],"the":[6,110],"standard":[7],"for":[8,80,262],"induction":[9,99],"(along":[10],"with":[11,18,24,37,57,65,107,120,158,184,228,232,257,304,314,365],"glucocorticoid)":[12],"and":[13,33,46,71,83,126,146,161,208,245,265,307,341,355,394],"maintenance":[14,135],"therapy":[15,32,136,143,313],"of":[16,39,61,92,112,150,235,333,380],"patients":[17,23,374],"AAV.":[19],"We":[20],"report":[21],"2":[22,81,102,104,180],"AAV":[25,229,373],"who":[26],"had":[27,153],"active":[28,170,326],"disease":[29],"despite":[30,141,312],"RTX":[31,98,113,134,142,258,271],"were":[34,319],"successfully":[35],"treated":[36,64,256],"combination":[38,382],"Obinutuzumab":[40],"(OBZ)":[41],"(a":[42],"type":[43],"II":[44],"anti-CD20)":[45],"Avacopan":[47,185,336,366],"(C5aR":[48],"antagonist).":[49],"Case":[50],"Description:":[51],"Patient":[52,222],"1:":[53],"80-year":[54],"old":[55],"female":[56,225],"a":[58,233,246,296,387],"10-year":[59],"history":[60],"microscopic":[62],"polyangiitis":[63],"mycophenolate":[66],"(MPA)":[67],"(for":[68],"6":[69,274],"years)":[70],"prednisone":[72],"(PRED).":[73],"She":[74,130,215,253,267,329],"relapsed":[75],"after":[76,196,230],"being":[77],"off":[78],"immunosuppression":[79],"years":[82],"was":[84,95,118,131,226,254,268,292],"re-initiated":[85],"on":[86,133,270],"MPA":[87],"therapy.":[88],"Due":[89],"to":[90,97,212,281,294,360,376,391],"lack":[91],"response,":[93],"she":[94,152,175,291],"switched":[96],"1g":[100,178],"x":[101,179],"doses":[103,181,264],"weeks":[105],"apart":[106,183],"PRED.":[108,266],"At":[109,190],"time":[111],"induction,":[114],"serum":[115],"creatinine":[116],"(Scr)":[117],"1.5":[119,282],"MPO-ANCA":[121],"titers":[122,163,241,357],">":[123,164,242,288,309],"8.0":[124,165,243,310],"U":[125,244,311],"hematuria":[127,160,205,237,305,353],"(3-10":[128,238],"RBC/HPF).":[129],"continued":[132,269],"(1g)":[137,272],"every":[138,273],"6-months.":[139],"However,":[140],"(18":[144],"months)":[145],"CD20+":[147,316],"B":[148,317],"cell":[149],"zero,":[151],"rising":[154],"Scr":[155,199,234,278,298,347],"2.1":[156],"mg/dL":[157,303],"persistent":[159],"MPO":[162,209,240,285,308,356],"U.":[166,214,362],"Repeat":[167],"biopsy":[168,247,324],"showed":[169,249,325],"necrotizing":[171,251,327],"glomerulonephritis":[172],"(GN).":[173],"Therefore,":[174],"received":[176,330],"OBZ":[177,334,364],"2weeks":[182],"30":[186,337],"mg":[187,338],"twice":[188,339],"daily.":[189],"last":[191],"follow":[192],"up":[193],"(9":[194],"months":[195,344],"OBZ),":[197],"her":[198,277,284],"stable":[201,349],"at":[202,301,350],"2.0":[203],"mg/dL,":[204,283,352],"completely":[206],"resolved":[207,354],"down":[211,359],"1.1":[213],"has":[216],"not":[217],"experienced":[218],"any":[219],"adverse":[220,395],"events.":[221],"2:":[223],"47-year-old":[224],"diagnosed":[227],"presenting":[231],"2.6,":[236],"RBC/HPF),":[239],"that":[248,299],"pauci-immune":[250],"GN.":[252,328],"initially":[255,279],"375":[259],"mg/m2":[260],"weekly":[261],"4":[263],"months.":[275],"Although":[276],"improved":[280],"remained":[286],"persistently":[287],"8.0.":[289],"Subsequently,":[290],"noted":[293],"have":[295],"worsening":[297],"peaked":[300],"2.4":[302],"(100/HPF)":[306],"RTX.":[315,377],"cells":[318],"zero.":[320],"A":[321],"repeat":[322],"kidney":[323],"1":[331],"dose":[332],"1g,":[335],"daily":[340],"prednisone.":[342],"Six":[343],"following":[345],"OBZ,":[346],"2.2":[351],"are":[358],"5.8":[361],"Discussion:":[363],"can":[367],"be":[368,384],"an":[369],"effective":[370],"strategy":[371],"in":[372],"resistant":[375],"The":[378],"efficacy":[379],"this":[381],"should":[383],"evaluated":[385],"through":[386],"randomized":[388],"clinical":[389],"trial":[390],"determine":[392],"outcomes":[393],"effects.":[396]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2024-05-19T00:00:00"}